The fetal growth restriction at term managed by angiogenic factors versus feto-maternal doppler (GRAFD) trial to avoid adverse perinatal outcomes: Protocol for a multicenter, open-label, randomized controlled trial

by biblioteca on 23 de gener de 2023 with No hi ha comentaris

Garcia-Manau, P., Mendoza, M., Bonacina, E., Martin-Alonso, R., Martin, L., Palacios, A., . . ., Alcoz, M., Gomez-Valencia, E., Carreras, E. (2022). The fetal growth restriction at term managed by angiogenic factors versus feto-maternal doppler (GRAFD) trial to avoid adverse perinatal outcomes: Protocol for a multicenter, open-label, randomized controlled trial. JMIR Research Protocols, 11(10). https://doi.org/10.2196/37452